Progesterone is indispensable for differentiation of human endometrial stromal cells (HESCs) into decidual cells, a process that critically controls embryo implantation. We now show an important role for androgen receptor (AR) signaling in this differentiation
ulates all aspects of female reproduction, from ovulation and embryo implantation to parturition. The actions of progesterone (P4) on reproductive target tissues are mediated predominantly by its cognate nuclear receptors, P4 receptor (PR)-A and PR-B, members of the superfamily of ligand-dependent transcription factors. In the uterus, the postovulatory rise in P4 levels induces differentiation of the endometrial mucosa in preparation for pregnancy (1) . A cardinal event in this remodeling process is the transformation of endometrial stromal fibroblast into secretory, epithelioid-like decidual cells (2) (3) (4) . In addition to the morphological changes, decidualization bestows some unique functional properties on human endometrial stromal cells (HESCs), including the ability to modulate local immune cells, to resist environmental stress signals, and to modulate trophoblast invasion (2) (3) (4) . Mice deficient in PR fail to mount a decidual response and are sterile (1) . However, activation of PR is in itself insufficient to induce decidualization in mice or humans. Initiation of HESC differentiation is strictly dependent upon elevated cAMP levels and sustained activation of the protein kinase A pathway, which in turn sensitize the cells to P4 (5, 6) . Once decidualized, the endometrium becomes inextricably dependent upon continuous P4 signaling for homeostasis, and in the absence of pregnancy, falling P4 levels trigger a cascade of events that results in apoptosis, proteolytic breakdown of the superficial endometrium, focal bleeding, and menstrual shedding (7) .
HESCs also abundantly express the androgen receptor (AR) (8, 9 ), yet little is known about the function of this nuclear receptor family member in the decidual process. AR and PR are phylogenetically closely related and share 54 and 80% sequence homology in their ligand-and DNA-binding domains, respectively (10) . AR expression, which is confined to the stroma in cycling endometrium, decreases during the secretory phase, although the receptor remains detectable in the decidua of early pregnancy (11, 12) . Serum androgen levels fluctuate throughout the menstrual cycle, with levels peaking around ovulation (13, 14) . However, tissue androgen levels and conversion of androstenedione to testosterone are higher in secretory than proliferative endometrium (15) . Moreover, a rise in circulating androgen levels in the late luteal phase is associated with a conception cycle and levels continue to rise in early pregnancy (16) . Interestingly, both lack and excess of circulating androgens in premature ovarian failure and polycystic ovary syndrome, respectively, are associated with increased risk of early fetal loss and late obstetric complication due to impaired placental function, such as preeclampsia (17) (18) (19) . The medium was collected and assayed for PRL concentration. The data are expressed as percentage increase over cAMPϩP4 alone (mean ϮSD). C, RTQ-PCR analysis was carried out for PRL mRNA levels in cultures treated as in A. The results show mean PRL mRNA levels (ϮSD) normalized to L19 mRNA of three independent cultures. D, HESCs were treated as in A for 48 h followed by transfection with dPRL-3000/Luc. Subsequently, the cells were maintained in the same culture conditions for 24 h. Luciferase and galactosidase assays were performed, and the results represent the mean (ϮSD) of triplicate measurements of one representative experiment. E, Primary HESCs were cultured in the presence of 8-br-cAMP, P4, DHT, and bicalutamide (Casodex; CDX) as indicated and PRL secretion determined as described above. PRL secretion was significantly different between cAMP/P4/DHT-and cAMP/P4/DHT/CDX-treated cultures (*, P Ͻ 0.05). F, HESCs, decidualized with a combination of 8-Br-cAMP, P4, and DHT for 48 h, were either mock-transfected or transfected with NT or AR siRNAs. The treatments were continued for 72 h and the supernatants assayed for PRL. The data represent the relative effect of DHT (percent) on decidual PRL secretion (mean Ϯ SD) of triplicate cultures normalized to total protein content of each well (*, P Ͻ 0.01).
These observations provide compelling but circumstantial evidence that androgens play a role in decidual-trophoblast interactions in pregnancy. We now demonstrate that decidualization of HESCs is associated with increased responsiveness to androgen signaling. Compared with PR, AR controls a much smaller but focused network of genes essential for cytoskeletal organization and cell cycle regulation in decidualizing endometrium.
Materials and Methods

Primary endometrial cell culture
The Local Research and Ethics Committee at Hammersmith Hospitals NHS Trust approved the study, and patient consent was obtained before tissue collection. HESC cultures were established as previously described (2) . Cultures were decidualized with 0.5 mm 8-Br-cAMP (Sigma Chemical Co., St. Louis, MO) and medroxyprogesterone acetate (MPA; Sigma), P4 (Sigma), dihydrotestosterone (DHT; Sigma), or bicalutamide (Casodex; AstraZeneca, London, UK), all at 1 m bar for DHT, which was used at 0.1 m concentration unless stated otherwise.
Transfections
Primary HESCs were transfected with DNA vectors or small interfering RNA (siRNA) by the calcium phosphate coprecipitation method using the Profection mammalian transfection kit (Promega, Madison, WI), as previously described (2) . All transfections were performed in triplicate in 24-well plates and repeated at least three times. The expression plasmids for AR, PR-B, PIAS1, PIAS1(C351S, W372A), and EGFP-SUMO1 have been described (2, 6) . The reporter constructs dPRL3000/Luc and PRE2/-32dPRL/Luc were a gift from B. Gellersen (Endokrinologikum Hamburg, Hamburg, Germany) The concentration of reporter constructs and expression vectors was 400 and 100 ng/well, respectively. The control vector pCH110 (50 ng/well), which leads to constitutive ␤-galactosidase expression, was used to compare transfection efficiency. For gene silencing studies, HESCs were cultured in six-well plates until confluency and transiently transfected with 100 nm of the following siRNA reagents (Dharmacon, Lafayette, CO): siCONTROL nontargeting (NT) siRNA Pool, AR siGENOME SMARTpool siRNA, PR siGENOME SMARTpool siRNA, and PIAS1 siGENOME SMARTpool siRNA.
Western blot analysis and prolactin (PRL) and insulin-like growth factor-binding protein-1 (IGFBP-1) assays
Whole-cell lysates and nuclear protein fractions were obtained as described elsewhere (4, 6) . Proteins (30 g) were separated on a 10% SDS-polyacrylamide gel before electrotransfer onto nitrocellulose membrane (Amersham, Little Chalfont, UK). The following primary antibodies were used: monoclonal AR (Biogenix, San Ramon, CA), mouse monoclonal PR (Novocastra Laboratories, Newcastle-Upon-Tyne, UK), mouse monoclonal ␤-actin (Abcam, Cambridge, UK), rabbit total and phosphorylated (Ser 473 ) AKT (Cell Signaling, Hitchin, UK), rabbit total and phosphorylated (Thr 202/204 ) ERK1/2 (Cell Signaling), mouse ␤-catenin (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit phosphorylated (Ser 807/811 ) pRB (Cell Signaling), rabbit phosphorylated MLC (Ser 19 ) (Cell Signaling), rabbit IL1R1 (Abcam), and rabbit signal transducer and activator of transcription 3 (STAT3) and STAT5b (Upstate Biotechnology, Lake Placid, NY). Primary antibodies were diluted to 1:1000 except ␤-actin, which was used at 1:100,000. Secondary antibodies were diluted at 1:2000 dilution and protein complexes visualized with a chemoluminescent detection kit (Amersham). PRL in the HESC culture media was measured by microparticle enzyme immunoassay (AxSYM system; Abbott Laboratories, North Chicago, IL). IGFBP-1 levels in culture media were determined using an amplified two-step sandwich-type immunoassay (R&D Systems, Minneapolis, MN). 
Microarray and real-time quantitative (RTQ)-PCR
Gene expression profiling was performed on four independent primary cultures, established from proliferative-phase biopsies. Total RNA was isolated from cultured HESCs using Stat-60 (Tel-Test, Friendswood, TX). Genomic DNA was removed by deoxyribonuclease treatment, and the quality of the RNA was evaluated using a Bioanalyzer 2100 (Agilent Technologies Inc., Santa Clara, CA). All subsequent steps were carried out at the Finnish DNA-Microarray Centre using the Sentrix Human Illumina 6 V1 Expression BeadChips (Illumina, San Diego, CA), which contains over 47,000 known genes, gene candidates, and splice variants. Three hundred nanograms of each RNA sample, with 260/280 and 28S/18S ratio of greater than 1.8, was used to make double-stranded cDNA and then biotinylated cRNA using the Illumina RNA TotalPrep Amplification Kit (Ambion Inc., Austin, TX). Labeled cRNA was purified and hybridized to the BeadChip at 55 C, for 17 h after the Illumina Whole-Genome Gene Expression Protocol for BeadStation. Hybridized biotinylated cRNA was detected with cyanine3-streptavidin (Amersham). Arrays were scanned with the Illumina BeadArray Reader, which is a confocaltype imaging system with about 0.8-m resolution and 532-nm laser illumination. The normalization and statistical analyses of the microarrays were performed using the statistical software R package limma (http://www.R-project.org). Genes of coefficient of variation values higher than 0.8 were filtered out from the analysis in preprocessing. The same software was used for single-gene analyses including fold-change calculations. The normalized data were analyzed by pair-wise comparisons to create a list of differentially expressed genes. Because we have shown that HESCs decidualized for 72 h are only modestly sensitive to androgen signaling, differentially expressed genes were defined by a lower boundary of a 99% confidence interval of fold change greater than 1.2 as validated by Student's t test (P Ͻ 0.01). To interpret the biological significance of differentially expressed genes, a gene ontology analysis was conducted using Ingenuity Pathways Analysis (IPA, Ingenuity Systems, http://www.ingenuity.com). RTQ-PCR analysis was performed as previously described (4) . All measurements were performed in triplicate. Genespecific primer pairs were designed using the ABI Primer Express software (supplemental Table 1 , published as supplemental data on The Endocrine Society's Journals Online web site at http:// endo.endojournals.org).
Fluorescence microscopy, motility, and proliferation assays
Immunofluorescence analysis was performed on cells seeded onto glass coverslips, fixed in 4% paraformaldehyde, permeabilized with 0.5% Triton, and stained with tetramethylrhodamine isothiocyanatelabeled phalloidin (Chemicon, Temecula, CA) and counterstained with 4Ј,6-diamidino-2-phenylindole. The number of cells with actin stress fibers per 100 cells was determined by an independent assessor, blinded to the treatment, in three independent experiments. Cell motility was assessed by time-lapse microscopy using an inverted microscope with a motorized stage. Images were captured every 15 min over a 48-h period using a Hamamatsu C4742-95 CCD camera, and the distance each cell moved was analyzed using Image Pro Plus software (Media Cybernetics, Silver Spring, MD). Triplicate experiments were performed, and at least 15 cells per field of view, chosen randomly, were analyzed. Proliferation was ascertained using CellTiter 96 Aqueous One Solution Cell Proliferation Assay (Promega).
Results and Discussion
Increased androgen responses in decidualizing HESCs
Secretion of PRL and IGFBP-1 in response to cAMP and P4 signaling is the hallmark of decidual transformation of HESCs (2) . To test whether androgens modify this differentiation process, primary HESC cultures were treated with 8-Br-cAMP, P4, and DHT, either alone or in combination over a time course lasting 8 d. Treatment with P4 alone was insufficient to trigger expression of either differentiation marker (Fig. 1A) . In contrast, 8-Br-cAMP rapidly increased PRL and IGFBP-1 secretion, but expression declined after 4 d of treatment. As expected (2), enhanced and sustained expression of both IGFBP-1 and PRL in long-term cultures required both 8-Br-cAMP and P4 signaling. DHT also modestly enhanced the expression of both marker proteins in 8-Br-cAMP-treated cultures, but in contrast to P4, DHT was insufficient to sustain the decidual response in prolonged culture. Interestingly, DHT markedly enhanced PRL but not IGFBP-1 secretion in cultures treated with 8-Br-cAMP plus P4. This androgen response in decidualizing cultures increased in magnitude over time in a dose-dependent manner (Fig. 1B) . RTQ-PCR analysis demonstrated that the changes in PRL transcript levels mirrored those at the protein level (Fig. 1C ). In addition, transfection studies with dPRL3000/ Luc, a luciferase reporter construct coupled to 3 kb of the decidua-specific PRL promoter region (20) , revealed that the pattern of PRL expression in response to cAMP, P4, and DHT corresponded to promoter activation (Fig. 1D) .
To determine whether AR mediates the effect of DHT on PRL expression, primary cultures were first treated with 8-Br-cAMP plus P4 in the presence or absence of DHT and the nonsteroidal pure AR antagonist bicalutamide. This antiandrogen entirely negated the ability of DHT to enhance PRL secretion (Fig. 1E) . Next, we transfected primary cultures, pretreated for 48 h with 8-Br-cAMP and P4 in the presence or absence of DHT, with either NT siRNA or siRNA targeting AR. Notably, AR depletion was very efficient (see 3A ) and abolished the ability of DHT to enhance PRL secretion in cells differentiated with 8-Br-cAMP and P4 (Fig.  1F) . Together, the results unequivocally demonstrate that androgen actions in decidualizing HESCs are dependent upon AR activation.
Decidualization decreases small ubiquitin-like modifier (SUMO)-1 modification of the activated AR
We postulated that enhanced AR expression could account for the gradual increase in androgen sensitivity upon HESC differentiation. However, treatment of primary cultures with 8-Br-cAMP alone resulted in rapid but transient reduction in AR levels ( Fig. 2A) . Conversely, P4 had little effect on AR levels in short-term cultures but down-regulated receptor levels after 6 -8 d of treatment. Combined 8-Br-cAMP plus P4 treatment resulted in a rapid and sustained decrease in cellular AR levels. DHT strongly increased AR levels in undifferentiated cells ( Fig.  2A) , as described in other cell systems (21) , but only partially antagonized the down-regulation of the receptor in decidualizing cells. Thus, as reported for P4 (2) , increased sensitivity to androgens in HESCs is paradoxically associated with decreasing receptor levels.
In the case of P4, increased responsiveness has been linked to global changes in cellular sumoylation upon HESC differentiation (6). More specifically, decidualization is characterized by a gradual decline in the expression of the E3 SUMO ligase protein inhibitor of activated STAT1 (PIAS1), resulting in attenuated ligand-dependent sumoylation of PR, increased transcriptional activity, and enhanced receptor turnover. PIAS1 also serves as an E3 ligase for AR (22) . This prompted an analysis of AR sumoylation in undifferentiated and decidualizing HESCs. Untreated cultures and cells first decidualized with 8-Br-cAMP or 8-Br-cAMP plus P4 for 48 h were transfected with expression vectors encoding AR and enhanced green fluorescent protein (EGFP)-tagged SUMO-1 and pulsed 24 h later with DHT. Immunoblotting of cell lysates with an anti-AR antibody demonstrated the presence of two slower migrating forms of AR in undifferentiated cells, first apparent after 10 min DHT stimulation, which represent SUMO-1 modification of the two known acceptor sites (K386 and K520) in AR (Fig. 2B) (22) . Compared with undifferentiated HESCs, DHT-dependent sumoylation of AR was attenuated in cells treated with 8-br-cAMP and much more so in cultures decidualized with 8-Br-cAMP plus P4. Next, we confirmed in COS-1 cells that increasing expression 
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Gene symbols in bold indicate genes known to be regulated in endometrium. Genes implicated in cytoskeletal organization are referenced.
of PIAS1 enhances ligand-dependent AR sumoylation (supplemental Fig. 1 ) and, conversely, that PIAS1 knockdown reduces AR SUMO-1 modification in HESCs treated with DHT (Fig. 2C) . To explore whether PIAS1 regulates endogenous androgen responses in HESCs, we first overexpressed wild-type PIAS1 or a PIAS1 mutant (C351S, W372A) devoid of E3-ligase activity in cells decidualized with 8-Br-cAMP and DHT for 48 h. Parallel cultures were harvested after 24 h for protein and mRNA analyses. As shown in Fig. 2D , wild-type but not mutant PIAS1 enhanced SUMO-1 modification of AR, which corresponded to a 50% decrease in PRL mRNA expression. Notably, expression of the E3-deficient mutant antagonized endogenous PIAS1, resulting in decreased AR sumoylation and higher PRL mRNA levels. Furthermore, PIAS1 knockdown in undifferentiated HESCs was sufficient to induce PRL expression in response to DHT without the need of additional decidualizing stimuli (Fig. 2E) . Together, the results demonstrate that down-regulation of PIAS1 upon decidualization sensitizes HESCs not only to P4 (6) but also to androgen signaling.
Identification of decidual AR and PR target genes
MPA, a 17-OH P4 derivative with known androgenic actions (23) , is widely used in combination with 8-BrcAMP to differentiate HESCs in vitro (2, 20) . We confirmed that MPA, like DHT but not P4, enhances cellular AR levels in HESCs, induces its nuclear accumulation, and transactivates the receptor in a reporter assay (supplemental Fig. 2) . We exploited the progestogenic and androgenic properties of MPA to search for specific AR-and PRdependent genes in decidualizing HESCs. Four separate primary cultures were first transfected with either NT siRNA oligos or a siRNA pool targeting AR or PR and then treated with 8-Br-cAMP plus MPA for 72 h. Parallel cultures were harvested for mRNA and protein analysis. As shown in Fig. 3A , the siRNA knockdown approach for AR and PR was effective and selective at both the mRNA and protein level. Furthermore, knockdown of either receptor was equally efficient in attenuating PRL mRNA expression in differentiating HESCs (Fig. 3B) . Total RNA was then processed for genome-wide expression profiling, and the data were interrogated using parametric statistical testing. Figure 3C represents the Venn diagram of regulated genes identified by the following pair-wise comparisons: AR siRNA-transfected cells (AR) vs. NT siRNA-transfected cells and PR siRNA-transfected cells (PR) vs. NT siRNAtransfected cells. AR knockdown affected the expression of a relatively small pool of genes. Of the 92 transcripts deregulated upon AR depletion, the expression of 42.4 and 57.6% of transcripts were up-and down-regulated, respectively (Tables 1 and 2 ). In contrast, PR knockdown perturbed the expression of 860 genes, 55.6% of which were up-regulated and 44.4% down-regulated. Tables 3  and 4 list the 50 most induced and repressed PR-dependent genes, respectively. We identified only 29 genes under control of both nuclear receptors in decidualizing cells, although 10 were regulated in an opposing manner (Table 5) . Thus, the data confirm the major role of PR in regulating decidual gene expression and define, for the first time, a smaller but distinct set of genes under AR control. Because all cultures were decidualized before array analysis, we cross-referenced our genes lists with the Endometrium Database Resource (http://endometrium.bcm.tmc. edu/edr/) and annotated the tables to indicate genes already reported to be regulated upon endometrial differentiation. RTQ-PCR validation of genes under the putative control of AR (IL1R1, DUSP3, and OIP5), PR (MMP10, TWIST1, and RASD1), or both AR and PR (KCNK3, PCDH7, and WNT4) yielded no false-positive results (Fig. 4) . Interestingly, not all identified target genes were dependent upon ligand activation of the receptor. For instance, DUSP3 (dual-specificity phosphatase 3) mRNA levels remained unchanged upon HESC differentiation, yet transfection of AR siRNA resulted in a 3-fold decrease in the transcript levels of this negative regulator of the MAPK pathway. Similarly, MMP10 (matrix metalloproteinase 10) expression was strongly repressed in differentiating HESCs, and PR knockdown not only reversed this repression but also elicited a 4-fold increase in MMP10 mRNA levels when compared with undifferentiated cells, suggesting that even the unliganded PR plays a role in repressing MMP expression in human endometrium. Gene symbols in bold indicate genes known to be regulated in endometrium.
PR is indispensable for activation of secondary signaling pathways upon decidualization
Microarray analyses have been extensively used to examine endometrial responses to P4 in humans and various animal models (24 -26) . Our gene profiling complements these studies and confirms that PR controls the expression of a network of at least 860 genes in decidualizing HESCs. Ingenuity Pathway Analysis clustered PR-dependent genes into 28 different functional molecular and cellular categories (supplemental Fig. 3) , and many can be functionally linked to known P4 actions in the endometrium. For instance, P4 critically ensures tissue integrity of the decidualizing endometrium before menstruation and during pregnancy (3, 7), and not unexpectedly, several genes repressed in a PR-dependent manner encode for matrix metalloproteinases (MMP2, -8, -10, -11, and -27), death receptors of the tumor necrosis factor receptor superfamily (TNFRSF10B, -10D, -11B, -19, and -21), apoptosis mediators (e.g. MCL1, NR4A2, BCL2L10, TRAF4, TP53INP, MOAP1, SEMA3F, DAD1, CIAPN1, DEDD, and MAP3K5), and oxidative stress defenses and DNA repair (e.g. TXNRD1, HNOX1, PPP1R15A, and XRCC5).
Although insufficient to trigger HESC differentiation, Gene symbols in bold indicate genes known to be regulated in endometrium.
P4 is essential for maintaining the decidual phenotype both in vivo and in vitro. Compelling evidence has emerged to indicate that sustained expression of the decidual phenotype is also dependent on autocrine or paracrine signals, resulting in activation of various secondary signaling pathways (5, 27, 28) . Strikingly, a significant number of PR-dependent genes encode for ligands, membranebound receptors, and intermediates in various signal transduction pathways (supplemental Fig. 4 ). This prompted us to examine the expression and/or activation status of critical signal intermediates in the STAT, MAPK (ERK1/2), PI3K, TGF␤/SMAD, and WNT/␤-catenin pathways in undifferentiated HESCs and decidualized cells transfected with AR or PR siRNAs. In agreement with the gene profile, PR knockdown selectively abolished the induction of STAT3 and STAT5b upon HESC differentiation (Fig. 5) . Total ERK1/2, AKT, SMAD2, and ␤-catenin levels remained unchanged upon differentiation of HESCs. However, decidualization was accompanied by a down-regulation in activated (phosphorylated) AKT levels and a reciprocal increase in ERK1/2 phosphorylation, yet the activation status of either pathway was unaffected by AR or PR depletion. In contrast, PR knockdown eliminated nuclear accumulation of activated SMAD2 and ␤-catenin in differentiating HESCs. The data imply that a substantial proportion of PR-dependent decidual genes are regulated indirectly, via autocrine or paracrine activation of the WNT/␤-catenin, TGF␤/SMAD, and STAT pathways.
AR regulates cytoskeletal organization and cell cycle inhibition
Ingenuity pathway analysis complemented by manual mining of available literature implicated 40% (21 of 53) of genes down-regulated upon AR silencing in the regulation of cell morphology, cytoskeletal organization, and cell motility (Tables 1 and 5 ). This prompted us to examine more closely the differentiation-associated changes in the actin cytoskeleton by phalloidin staining of filamentous actin (F-actin). As shown in Fig. 6A , decidualization is characterized by a dramatic increase in F-actin polymerization and stress fiber formation. However, the proportion of cells that express elongated stress fibers was reduced by approximately 50% upon AR knockdown, whereas PR silencing had no apparent effect ( Fig. 6A and  supplemental Fig. 5 ). Time-lapse microscopy demonstrated that decidualization is also associated with a dramatic decrease in basal cell motility, which was partially reversed upon AR knockdown (Fig. 6B) . Actin-myosin interactions are essential for cell motility and promoted by phosphorylation of the regulatory light chain of myosin 2 (MLC2) (29) . In agreement with the motility studies, AR knockdown was sufficient to reverse loss of MLC2 phosphorylation upon decidualization of HESCs (Fig. 6C) .
In addition to cell motility, the actin cytoskeleton is involved in many other biological functions, including endoand exocytosis, cytokinesis, and signal transduction (30, 31), Gene symbols in bold indicate genes known to be regulated in endometrium. Genes implicated in cytoskeletal organization are referenced.
underscoring the importance of AR in regulating decidual cell function. Importantly, induction of the IL-1 receptor (IL1R1) in decidualizing cells is under AR control (Fig. 4) . Embryonic signals, and in particular IL-1␤, have been shown to activate focal adhesion kinase (FAK) and to further promote cytoskeletal reorganization in decidual cells (32) . Together, these observations suggest AR plays a major role in coordinating decidual-trophoblast interactions during early pregnancy. This conjecture is further supported by the observation that inactivation of decidual RhoA, a Rho GTPase family member essential for cytoskeletal organization, blocks outgrowth but not attachment of blastocysts in a coculture model (33) .
In silico analysis further revealed that several genes upregulated in decidualizing cells upon AR depletion, and thus normally repressed in an AR-dependent manner, are involved in various aspects of cell cycle regulation (e.g. NAP1L1, WEE1, BM88, XTP3TA, and IMPDH2) including DNA replication licensing (e.g. CDT1, MCM4, and MCM2) and chromatid separation (e.g. CHTF18, DIPA) (Tables 2 and   5 ). This expression profile points toward a role for AR in safeguarding the genetic stability of the endometrium during rapid cyclic remodeling. Functionally, AR knockdown enhanced proliferation of HESCs decidualized with 8-Br-cAMP and MPA (Fig. 6D) . In contrast, proliferation was modestly but consistently reduced upon PR knockdown. Inactivation of retinoblastoma protein (RB) by hyperphosphorylation enables the expression of E2F-target genes essential for coordinating entry into S phase of the cell cycle (34) . As shown in Fig. 6E , differentiation of HESCs is strongly associated with loss of RB phosphorylation but much less so upon AR knockdown.
In summary, we have shown that HESCs become increasingly responsive to androgen signaling upon differentiation. This increased sensitivity to sex steroids, whether androgens or P4, is directly linked to global changes in cellular sumoylation and, more specifically, to differentiation-dependent down-regulation of PIAS1, the E3 SUMO-1 ligase of AR and PR. In comparison to PR, AR governs the expression of a limited decidual gene pool, responsible for cytoskeletal organization and inhibition of cell motility and proliferation. These cell functions under AR control may be critical for coordinated trophoblast invasion and placental development. This notion is supported by the observations in female AR-deficient mice, demonstrating that uterine responses to exogenous gonadotropins are impaired before developing premature ovarian failure (35) . Furthermore, the earliest reproductive defect in these mice is a dramatic reduction in the number of pups per litter, and pregnancy is further characterized by placentamegaly, which suggests a compensatory response to defective uterine remodeling (35, 36) . However, additional experiments are required to exclude the possibility that these early uterine defects in AR-deficient mice are a consequence of impaired ovarian steroidogenesis. The identification of human AR signature genes could be exploited to assess the decidual responses before pregnancy, especially in patients with relative androgen deficiency, including older women and patients with premature ovarian failure receiving fertility treatment with donor oocytes. Such translational studies may provide the in vivo rational for the targeted use of selective AR modulators for the prevention of associated pregnancy complications. 
